Drug
dextroamphetamine sulfate, dextroamphetamine saccharate, amphetamine aspartate monohydrate, and amphetamine sulfate
Marketed as MYDAYIS.
Generic name
dextroamphetamine sulfate, dextroamphetamine saccharate, amphetamine aspartate monohydrate, and amphetamine sulfate
Brand names
MYDAYIS
First FDA approval
2017-06-20
FDA approval history
| FDA ID | Brand | Approval date | Manufacturer |
|---|---|---|---|
| NDA022063 | MYDAYIS | 2017-06-20 | TAKEDA PHARMS USA |
Manufacturers
TAKEDA PHARMS USA
Frequently asked questions
When was dextroamphetamine sulfate, dextroamphetamine saccharate, amphetamine aspartate monohydrate, and amphetamine sulfate FDA approved?
Earliest FDA approval on record: 2017-06-20.
What brand names are sold as dextroamphetamine sulfate, dextroamphetamine saccharate, amphetamine aspartate monohydrate, and amphetamine sulfate?
MYDAYIS.
Sources
Appeal a dextroamphetamine sulfate, dextroamphetamine saccharate, amphetamine aspartate monohydrate, and amphetamine sulfate denial
Upload your denial — DenialHelp drafts a physician-ready appeal letter in five minutes with the right clinical guideline and federal regulation cited. $39 first-level, money back if we can't draft a strong appeal.
Get started →Contact: hello@denialhelp.com